ADAGE CAPITAL PARTNERS GP, L.L.C.
Q2 2020 13F-HR Holdings
Net value change ($000)
+5,571,330
(16.6%)
New positions
114
Sold out positions
113
Turnover %
21.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| RPRX | 2,234,044 | NEW |
| AAPL | 468,434 | 37.6% |
| MSFT | 398,726 | 28.2% |
| AMZN | 356,675 | 36.0% |
| BURL | 250,901 | 118.7% |
| OTIS | 211,311 | NEW |
| ABBV | 198,550 | NEW |
| W | 189,706 | NEW |
| Horizon Therapeutics Public Ltd Co | 180,966 | NEW |
| RTX | 173,169 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Allergan plc | -1,659,392 | -100.0% |
| LMT | -300,683 | -86.4% |
| JNJ | -230,633 | -75.0% |
| PFE | -152,567 | -71.5% |
| BMY | -122,477 | -100.0% |
| HON | -120,074 | -61.9% |
| RTX | -114,597 | -100.0% |
| VZ | -109,628 | -37.8% |
| RAYTHEON CO/ | -107,333 | -100.0% |
| VRTX | -100,738 | -46.5% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|